|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.03 USD | -1.66% |
|
+1.60% | -15.42% |
| Capitalization | 1.14B 981M 919M 856M 1.58B 103B 1.72B 10.74B 4.15B 48.49B 4.28B 4.19B 177B | P/E ratio 2025 * |
29.6x | P/E ratio 2026 * | 26.1x |
|---|---|---|---|---|---|
| Enterprise value | 1.24B 1.07B 1B 933M 1.72B 112B 1.87B 11.7B 4.52B 52.81B 4.66B 4.56B 193B | EV / Sales 2025 * |
1.6x | EV / Sales 2026 * | 1.45x |
| Free-Float |
85.83% | Yield 2025 * |
2.4% | Yield 2026 * | 2.42% |
Last Transcript: U.S. Physical Therapy, Inc.
| 1 day | -1.66% | ||
| 1 week | +1.60% | ||
| Current month | +1.60% | ||
| 1 month | -3.26% | ||
| 3 months | -12.39% | ||
| 6 months | -2.87% | ||
| Current year | -15.42% |
| 1 week | 71.77 |  | 77.13 |
| 1 month | 66.67 | | 79.4 |
| Current year | 62.77 | | 93.5 |
| 1 year | 62.77 | | 98.11 |
| 3 years | 62.77 | | 124.11 |
| 5 years | 62.77 | | 143.67 |
| 10 years | 45.13 | | 148.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 2003-10-31 | |
Eric Williams
PSD | President | 60 | 2024-05-20 |
| Director of Finance/CFO | 62 | 2020-11-08 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 2024-05-20 | |
Bernard Harris
BRD | Director/Board Member | 68 | 2005-08-22 |
Clayton Trier
BRD | Director/Board Member | 73 | 2005-02-22 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.36% | 22 M€ | +1.27% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.66% | +1.60% | -21.91% | -15.64% | 1.14B | |
| +1.08% | +1.69% | +14.75% | +44.33% | 18.06B | |
| +0.62% | -1.74% | -23.44% | -49.20% | 14.86B | |
| -0.16% | -1.99% | -0.61% | +50.16% | 11.49B | |
| -0.46% | -3.20% | +9.76% | +97.40% | 11.32B | |
| +0.02% | -4.08% | +23.39% | +94.44% | 10.24B | |
| -1.05% | -1.05% | -26.27% | -34.04% | 9.37B | |
| +0.37% | +6.75% | -17.74% | - | 8.14B | |
| 0.00% | -3.32% | +24.40% | +204.98% | 7.45B | |
| -2.37% | -1.52% | -9.94% | -45.39% | 5.53B | |
| Average | -0.36% | -0.75% | -2.76% | +38.56% | 9.76B | |
| Weighted average by Cap. | +0.00% | -0.93% | -0.28% | +40.86% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 778M 669M 626M 584M 1.08B 70.01B 1.17B 7.33B 2.83B 33.06B 2.92B 2.86B 121B | 826M 710M 665M 620M 1.15B 74.36B 1.25B 7.78B 3B 35.12B 3.1B 3.03B 128B |
| Net income | 45.93M 39.48M 36.98M 34.47M 63.67M 4.13B 69.25M 433M 167M 1.95B 172M 169M 7.14B | 43.96M 37.79M 35.4M 33M 60.94M 3.96B 66.29M 414M 160M 1.87B 165M 161M 6.83B |
| Net Debt | 102M 87.46M 81.93M 76.36M 141M 9.16B 153M 958M 370M 4.32B 382M 374M 15.81B | 60.37M 51.89M 48.61M 45.31M 83.69M 5.43B 91.03M 569M 220M 2.57B 227M 222M 9.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 75.03 $ | -1.66% | 174,403 |
| 25-12-04 | 76.30 $ | +1.18% | 131,636 |
| 25-12-03 | 75.41 $ | +2.64% | 132,809 |
| 25-12-02 | 73.47 $ | -0.07% | 164,250 |
| 25-12-01 | 73.52 $ | -0.45% | 114,118 |
Delayed Quote Nyse, December 05, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- USPH Stock
Select your edition
All financial news and data tailored to specific country editions
